The Board of Farmaforce is responsible for the corporate governance framework of the Company. The Board guides and monitors the business of Farmaforce on behalf of its shareholders.

The Board continues to be fully committed to achieving and demonstrating the highest standards of accountability and transparency in their reporting and see the continued development of the Company’s corporate governance policies and practices as fundamental to Farmaforce’s future and success.

The Board has adopted a Board Charter that clearly sets out those areas of governance reserved for the Board’s determination and articulates the division of responsibilities between the Board and the executive team.

Board Charter

The Board understands that the success of the Company will be enhanced by a strong ethical culture within the organisation. The need to ensure that ethical standards remain enshrined has led the Board to adopt a Code of Conduct to ensure that all Directors, executives and employees act with the utmost integrity and objectivity in all their dealings as representatives of Farmaforce.

Code of Conduct

The Board has included in its corporate governance policies those matters contained in the ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations 3rd Edition (where appropriate) and the Company’s Constitution.

In order to achieve its objectives and responsibilities, the Board has adopted the following corporate governance charters and policies.

Communications Strategy and Policy
Diversity Policy
Key Management Personnel Securities Trading Policy
Audit and Risk Committee Charter
Remuneration and Nomination Committee Charter
Continuous Disclosure Policy

Legal Notice

Whistleblowing Policy

Anti-bribery and Corruption Policy

Farmaforce is committed to all shareholders and the broader investment community having timely access to material information regarding the operations and results necessary to assess the Company’s overall performance. The Company will make regular ASX announcements and make these available on this website. Shareholders will also be provided with access to annual and half yearly reports via this website.

Shareholders are also encouraged, and will have the opportunity to participate at the Company’s Annual General Meeting to ensure accountability.

Download the Farmaforce Corporate Governance 2021 document here.